Evidence map›Paper›PMID 27193033›Full record

ArticleBMJ quality & safety2017

Cognitive tests predict real-world errors: the relationship between drug name confusion rates in laboratory-based memory and perception tests and corresponding error rates in large pharmacy chains.

Scott R Schroeder, Meghan M Salomon, William L Galanter, Gordon D Schiff, Allen J Vaida, Michael J Gaunt, Michelle L Bryson, Christine Rash, Suzanne Falck, Bruce L Lambert

Abstract read
In one paragraph

Article in BMJ quality & safety, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Dispensing errors from look-alike drug trade names.European journal of hospital pharmacy : science and practice · 2018
    Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Scott R SchroederCenter for Communication and Health, Department of Communication Studies, Northwestern University, Chicago, Illinois, USA.
Meghan M SalomonDepartment of Psychology, Northwestern University, Evanston, Illinois, USA.
William L GalanterDepartment of Medicine, University of Illinois, Chicago, USA.
Gordon D SchiffDepartment of General Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Allen J VaidaInstitute for Safe Medication Practices, Horsham, Pennsylvania, USA.
Michael J GauntInstitute for Safe Medication Practices, Horsham, Pennsylvania, USA.
Michelle L BrysonDepartment of Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois, USA.
Christine RashDepartment of Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois, USA.
Suzanne FalckDepartment of Medicine, University of Illinois, Chicago, USA.
Bruce L LambertCenter for Communication and Health, Department of Communication Studies, Northwestern University, Chicago, Illinois, USA.

Funding

Tools for Optimizing Medication Safety (TOP-MEDS)U19HS021093 · AHRQ · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LAMBERT, BRUCE L. · 2011 to 2015
$4.3M
AHRQ HHS U19 HS021093
6 · The paper itself

Abstract

backgroundDrug name confusion is a common type of medication error and a persistent threat to patient safety. In the USA, roughly one per thousand prescriptions results in the wrong drug being filled, and most of these errors involve drug names that look or sound alike. Prior to approval, drug names undergo a variety of tests to assess their potential for confusability, but none of these preapproval tests has been shown to predict real-world error rates.

objectivesWe conducted a study to assess the association between error rates in laboratory-based tests of drug name memory and perception and real-world drug name confusion error rates.

methodsEighty participants, comprising doctors, nurses, pharmacists, technicians and lay people, completed a battery of laboratory tests assessing visual perception, auditory perception and short-term memory of look-alike and sound-alike drug name pairs (eg, hydroxyzine/hydralazine).

resultsLaboratory test error rates (and other metrics) significantly predicted real-world error rates obtained from a large, outpatient pharmacy chain, with the best-fitting model accounting for 37% of the variance in real-world error rates. Cross-validation analyses confirmed these results, showing that the laboratory tests also predicted errors from a second pharmacy chain, with 45% of the variance being explained by the laboratory test data.

conclusionsAcross two distinct pharmacy chains, there is a strong and significant association between drug name confusion error rates observed in the real world and those observed in laboratory-based tests of memory and perception. Regulators and drug companies seeking a validated preapproval method for identifying confusing drug names ought to consider using these simple tests. By using a standard battery of memory and perception tests, it should be possible to reduce the number of confusing look-alike and sound-alike drug name pairs that reach the market, which will help protect patients from potentially harmful medication errors.

Indexed as

CognitionPharmaceutical PreparationsTerminology as TopicAdultAuditory PerceptionFemaleHumansLogistic ModelsMaleMedication ErrorsMemoryMiddle AgedNeuropsychological TestsPerceptionPharmaciesPhoneticsPharmaceutical PreparationsHuman errorHuman factorsMedication safetyPatient safety

Identifiers

PMID27193033
PMCPMC5530327

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.